Evidence map›Paper›PMID 41843008›Full record

ReviewApplied biochemistry and biotechnology2026

Recent Advances in the Manufacturing of Furfurylamine Through Biological and Chemobiological Ways.

Bright Uwase, Paul Arnaud Yao Koffi, Xiaohu Zhao, Yu-Cai He

Abstract readReview
PubMed Publisher
In one paragraph

Review in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bright UwaseSchool of Pharmacy & School of Biological and Food Engineering, Changzhou University, Changzhou, 213164, China.
Paul Arnaud Yao KoffiSchool of Pharmacy & School of Biological and Food Engineering, Changzhou University, Changzhou, 213164, China.
Xiaohu ZhaoSchool of Pharmacy & School of Biological and Food Engineering, Changzhou University, Changzhou, 213164, China.
Yu-Cai HeSchool of Pharmacy & School of Biological and Food Engineering, Changzhou University, Changzhou, 213164, China. yucaihe@cczu.edu.cn.

Funding

Frontier Technology Research and Development Plan of Jiangsu Province BF2025080
6 · The paper itself

Abstract

Catalytic upgrading of biomass is of paramount importance for the sustainable production of bio-based chemicals and biofuels. The direct use of polysaccharides, such as xylan and glucan, as starting materials is also possible in the preparation of biofurans. As one valuable biofuran, furfurylamine is recognized as a versatile intermediate, it is extensively used in manufacturing perfumes, resins, fibers, additives, and medicines. This review explores a sustainable approach to furfurylamine production that can be obtained entirely from agricultural and forestry wastes, including corncob, corn stalk, oat, and wheat bran. The procedure entails the hydrolysis of hemicellulose in biomass to liberate pentoses, succeeded by the dehydration of pentoses to generate furfural, which is then transformed into furfurylamine through biological amination. Key parameters such as catalyst selection, reaction conditions, and process optimization were investigated to enhance yield and selectivity. The results demonstrate the feasibility of manufacturing furfurylamine from hemicellulose-rich biomass, with significant advantages in terms of sustainability, cost-effectiveness, and reduced environmental impact compared to conventional methods. A life cycle assessment (LCA) and economic analysis further highlight the potential of this biomass-based route as a viable alternative to petrochemical processes. This review summarizes the recent advances, challenges and prospects of furfurylamine production from biomass, which provides a reference to the growing field of green chemistry by valorizing agricultural waste and providing a scalable, eco-friendly pathway for furfurylamine production via biological and chemobiological approach.

Indexed as

AminesBiotechnologyFuraldehydeFuransBiomassAminesFuraldehydeFuransBiomassChemoenzymatic approachFurfuralFurfurylamineω-Transaminase

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.